• Profile
Close

Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis

International Journal of Rheumatic Diseases Jul 11, 2018

Kamalaksha S, et al. - Data were collected prospectively from the Waikato Hospital Systemic Sclerosis (SSc) Clinics to assess the frequency of rheumatoid factor (RF) and anticyclic citrullinated peptide antibodies (anti-CCP) in the SSc cohort and their relationship with clinical features. For the purpose of this investigation, subjects with SSc and SOS (systemic sclerosis overlap syndrome) underwent baseline auto-antibody profiling including RF and anti-CCP along with annual clinical review. It was concluded that articular manifestations were common in SSc. The data presented in this work showed a statistically significant relationship of double antibody positivity with arthralgia and erosions. In addition, a significant association between anti-CCP antibody and erosions was found.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay